Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 02:48PM ET
253.95
Dollar change
+2.14
Percentage change
0.85
%
Index- P/E- EPS (ttm)-2.62 Insider Own0.81% Shs Outstand128.84M Perf Week0.35%
Market Cap32.75B Forward P/E- EPS next Y-1.08 Insider Trans-12.43% Shs Float127.94M Perf Month-6.98%
Income-332.26M PEG- EPS next Q-0.56 Inst Own96.57% Short Float2.92% Perf Quarter0.31%
Sales2.09B P/S15.64 EPS this Y43.24% Inst Trans3.10% Short Ratio4.84 Perf Half Y66.22%
Book/sh0.25 P/B1011.27 EPS next Y45.90% ROA-8.26% Short Interest3.74M Perf Year45.10%
Cash/sh21.56 P/C11.78 EPS next 5Y- ROE- 52W Range141.98 - 304.39 Perf YTD32.67%
Dividend Est.- P/FCF2039.52 EPS past 5Y14.18% ROI-12.65% 52W High-16.57% Beta0.32
Dividend TTM- Quick Ratio2.69 Sales past 5Y97.61% Gross Margin85.37% 52W Low78.87% ATR (14)7.67
Dividend Ex-Date- Current Ratio2.75 EPS Y/Y TTM36.38% Oper. Margin-8.98% RSI (14)45.89 Volatility1.98% 3.11%
Employees2100 Debt/Eq84.27 Sales Y/Y TTM21.54% Profit Margin-15.86% Recom1.85 Target Price305.46
Option/ShortYes / Yes LT Debt/Eq80.17 EPS Q/Q-175.33% Payout- Rel Volume0.27 Prev Close251.81
Sales Surprise-6.00% EPS Surprise5.08% Sales Q/Q-33.26% EarningsOct 31 BMO Avg Volume772.07K Price253.95
SMA200.22% SMA50-5.77% SMA20017.29% Trades Volume168,847 Change0.85%
Date Action Analyst Rating Change Price Target Change
Nov-12-24Downgrade Wolfe Research Peer Perform → Underperform
Oct-16-24Initiated Scotiabank Sector Outperform
Aug-16-24Upgrade Goldman Neutral → Buy $198 → $370
Feb-16-24Downgrade Goldman Buy → Neutral $173
Feb-15-24Initiated Wolfe Research Peer Perform
Dec-08-23Initiated Wells Fargo Equal Weight $171
Dec-08-23Initiated Wells Fargo Equal Weight
Oct-11-23Downgrade Oppenheimer Outperform → Perform
Sep-29-23Initiated Raymond James Outperform $208
May-05-23Upgrade BMO Capital Markets Market Perform → Outperform $200 → $250
Dec-04-24 12:00PM
Dec-02-24 02:48PM
Nov-27-24 07:00AM
05:38AM
Nov-25-24 04:16PM
07:00AM Loading…
07:00AM
Nov-22-24 02:16PM
Nov-18-24 07:24AM
Nov-17-24 09:30AM
Nov-15-24 07:19PM
Nov-06-24 12:26PM
04:27AM
Nov-04-24 08:00AM
Nov-01-24 10:34AM
03:05AM
01:11AM Loading…
01:11AM
12:25AM
Oct-31-24 10:00AM
09:10AM
08:07AM
08:00AM
Oct-30-24 11:31AM
08:00AM
Oct-28-24 09:16AM
Oct-24-24 10:01AM
Oct-23-24 12:00PM
Oct-17-24 09:40AM
08:00AM
Oct-16-24 08:00AM
Oct-09-24 12:14PM
07:00AM Loading…
07:00AM
07:00AM
Oct-08-24 07:41AM
Oct-07-24 03:00AM
Oct-01-24 09:40AM
08:03AM
Sep-29-24 09:00AM
Sep-26-24 08:00AM
Sep-14-24 07:03PM
Sep-13-24 07:10PM
Sep-12-24 01:01PM
Sep-08-24 02:01AM
Sep-06-24 07:09PM
Aug-30-24 04:19PM
04:03PM
02:33PM
02:33PM
10:13AM
06:00AM
02:00AM
Aug-28-24 04:00PM
Aug-23-24 10:22AM
Aug-21-24 02:45AM
Aug-07-24 09:00AM
08:00AM
Aug-04-24 06:55PM
Aug-02-24 09:45AM
06:39AM
01:03AM
Aug-01-24 07:25PM
11:30AM
09:15AM
08:14AM
08:00AM
Jul-30-24 09:15AM
Jul-25-24 10:01AM
Jul-18-24 08:00AM
06:05AM
Jul-11-24 06:30AM
Jul-09-24 06:00AM
Jul-08-24 04:52AM
Jul-05-24 03:01PM
Jun-25-24 07:45PM
08:59AM
Jun-24-24 09:41PM
04:11PM
01:54PM
01:54PM
01:05PM
12:52PM
12:42PM
12:32PM
10:53AM
10:52AM
10:33AM
10:25AM
10:24AM
10:06AM
08:51AM
07:00AM
06:49AM
04:20AM
04:20AM
Jun-05-24 06:14AM
May-07-24 09:12AM
08:00AM
May-03-24 01:01PM
12:29PM
10:48AM
03:11AM
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Greenstreet YvonneChief Executive OfficerNov 26 '24Sale250.985,2191,309,85378,880Nov 27 05:22 PM
Garg PushkalCMO & EVP Dev & Med AffairsNov 26 '24Sale250.981,682422,14417,457Nov 27 05:22 PM
Poulton Jeffrey V.EVP, Chief Financial OfficerNov 26 '24Sale250.981,682422,14430,644Nov 27 05:21 PM
Tanguler TolgaEVP, Chief Commercial OfficerNov 26 '24Sale250.981,469368,68613,191Nov 27 05:21 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchNov 27 '24Sale252.291,531386,26112,881Nov 27 05:20 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchNov 26 '24Sale250.981,469368,68614,412Nov 27 05:20 PM
Fitzgerald Kevin JosephOfficerNov 27 '24Proposed Sale253.981,531388,843Nov 27 04:06 PM
Greenstreet YvonneChief Executive OfficerAug 20 '24Option Exercise85.0015,0001,275,00088,441Aug 22 08:01 PM
Greenstreet YvonneChief Executive OfficerAug 20 '24Sale280.0015,0004,200,00073,441Aug 22 08:01 PM
Greenstreet YvonneOfficerAug 20 '24Proposed Sale280.0015,0004,200,000Aug 20 05:10 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchAug 12 '24Option Exercise89.0920,7251,846,42934,906Aug 14 04:12 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchAug 12 '24Sale270.9922,0255,968,51612,881Aug 14 04:12 PM
Fitzgerald Kevin JosephOfficerAug 12 '24Proposed Sale269.5222,0255,936,178Aug 12 04:07 PM
Ausiello Dennis ADirectorAug 06 '24Option Exercise119.6820,2502,423,45220,386Aug 08 04:10 PM
Ausiello Dennis ADirectorAug 06 '24Sale262.0020,2505,305,586136Aug 08 04:10 PM
Ausiello Dennis ADirectorAug 06 '24Proposed Sale266.6620,2505,399,865Aug 06 04:07 PM
Greenstreet YvonneChief Executive OfficerAug 01 '24Option Exercise85.0015,1481,287,58088,589Aug 02 08:01 PM
Greenstreet YvonneChief Executive OfficerAug 01 '24Sale270.0015,1484,089,96073,441Aug 02 08:01 PM
Greenstreet YvonneOfficerAug 01 '24Proposed Sale270.0015,1484,089,960Aug 01 04:01 PM
Greenstreet YvonneChief Executive OfficerJul 11 '24Sale261.007,0931,851,27373,441Jul 12 08:02 PM
SCHULMAN AMY WDirectorJun 25 '24Option Exercise131.218,5001,115,28516,936Jun 27 04:04 PM
SCHULMAN AMY WDirectorJun 25 '24Sale240.008,5002,040,0008,436Jun 27 04:04 PM
PYOTT DAVID E IDirectorJun 24 '24Option Exercise80.7632,4502,620,61132,586Jun 26 04:28 PM
PYOTT DAVID E IDirectorJun 24 '24Sale220.6932,4507,161,360136Jun 26 04:28 PM
Garg PushkalCMO & EVP Dev & Med AffairsJun 25 '24Sale230.992,103485,77315,609Jun 26 04:28 PM
Greenstreet YvonneChief Executive OfficerJun 25 '24Sale230.998,3011,917,47580,534Jun 26 04:27 PM
Poulton Jeffrey V.EVP, Chief Financial OfficerJun 25 '24Sale231.001,605370,74728,892Jun 26 04:26 PM
Tanguler TolgaEVP, Chief Commercial OfficerJun 25 '24Sale231.001,605370,74711,660Jun 26 04:26 PM
Fitzgerald Kevin JosephCSO & EVP, Head of ResearchJun 25 '24Sale230.991,198276,73114,181Jun 26 04:26 PM
SCHULMAN AMY WDirectorMay 29 '24Option Exercise66.8330,0002,004,90030,136May 31 07:00 PM
SCHULMAN AMY WDirectorMay 29 '24Sale148.6021,7003,224,5468,436May 31 07:00 PM
SHARP PHILLIP ADirectorFeb 29 '24Option Exercise59.2530,0001,777,50030,000Mar 01 04:12 PM
SHARP PHILLIP ADirectorFeb 29 '24Sale151.3430,0004,540,0710Mar 01 04:12 PM
Tanguler TolgaEVP, Chief Commercial OfficerFeb 27 '24Option Exercise0.001,66705,737Feb 29 04:18 PM
Tanguler TolgaEVP, Chief Commercial OfficerFeb 28 '24Sale155.3050177,8055,236Feb 29 04:18 PM
Poulton Jeffrey V.EVP, Chief Financial OfficerFeb 27 '24Option Exercise0.001,908020,052Feb 29 04:18 PM
Poulton Jeffrey V.EVP, Chief Financial OfficerFeb 28 '24Sale155.3057489,14519,478Feb 29 04:18 PM
Greenstreet YvonneChief Executive OfficerFeb 27 '24Option Exercise0.005,921051,060Feb 29 04:18 PM
Greenstreet YvonneChief Executive OfficerFeb 28 '24Sale155.312,932455,35748,128Feb 29 04:18 PM
Garg PushkalCMO & EVP Dev & Med AffairsFeb 27 '24Option Exercise0.001,90809,240Feb 29 04:17 PM
Garg PushkalCMO & EVP Dev & Med AffairsFeb 28 '24Sale155.3057489,1458,666Feb 29 04:17 PM
Franchini Indrani LallEVP, CLO & SecretaryFeb 27 '24Option Exercise0.0087804,462Feb 29 04:16 PM
Franchini Indrani LallEVP, CLO & SecretaryFeb 28 '24Sale155.3032951,0944,133Feb 29 04:16 PM
Garg PushkalCMO & EVP Dev & Med AffairsFeb 16 '24Sale148.061,308193,6667,332Feb 20 04:09 PM
Poulton Jeffrey V.EVP, Chief Financial OfficerFeb 16 '24Sale148.061,007149,09918,144Feb 20 04:08 PM
Tanguler TolgaEVP, Chief Commercial OfficerFeb 16 '24Sale148.061,009149,3974,070Feb 20 04:08 PM
Greenstreet YvonneChief Executive OfficerFeb 16 '24Sale148.067,0301,040,88545,139Feb 20 04:07 PM
Franchini Indrani LallEVP, CLO & SecretaryFeb 01 '24Option Exercise0.005,17505,175Feb 05 04:05 PM
Franchini Indrani LallEVP, CLO & SecretaryFeb 02 '24Sale170.991,591272,0503,584Feb 05 04:05 PM
BONNEY MICHAEL WDirectorDec 27 '23Option Exercise96.4530,0002,893,50046,029Dec 29 04:03 PM
BONNEY MICHAEL WDirectorDec 27 '23Sale195.0030,0005,850,00016,029Dec 29 04:03 PM